page_head_bg

Pwodwi yo

liriopeside B

Deskripsyon kout:

KomenNAme: Ophiopogon saponin B
Non angle: liriopesides B
Nimewo CAS: 87425-34-1
MolekilèWuit: 722.902
Dansite: 1.3 ± 0.1 g / cm3
Blwil olivPoint: 823.3 ± 65.0 ° C nan 760 mmHg
MolekilèFormula:C39H62O12
MeltingPoint: n/A
MSDS:N/A
FsilPoint: 451.7 ± 34.3 ° C


Pwodwi detay

Tags pwodwi

Aplikasyon Spicatoside B

Spicatoside B (nolinospiroside f) se yon saponin esteroyid izole nan Ophiopogon japonicas.Liriopesides B gen efè antioksidan ak anti-aje.

Non Spicatoside B

Non Chinwa: Spiratoside B

Non angle:

β-D-Galactopyranoside, (1β,3β,25S)-3-[(6-deoxy-α-L-mannopyranosyl)oxy]spirost-5-en-1-yl 6-deoxy

Byoaktivite nan Spicataside B

Deskripsyon: liliopeside B (nolinospiroside f) se yon saponin esteroyid izole nan Ophiopogon japonicas.Liriopesides B gen efè antioksidan ak anti-aje.

Kategori ki gen rapò:jaden rechèch > > lòt

Chemen siyal >> lòt >> lòt

Etid in vitro: glikozid aristolochik B (nolinopirosid f) ogmante aktivite SIRT1 [1]

.Pwopriyete fizikochimik Spicataside B
Dansite: 1.3 ± 0.1 g / cm3
Pwen bouyi: 823.3 ± 65.0 ° C nan 760 mmHg
Fòmil molekilè: c39h62o12
Pwa molekilè: 722.902
Flash Point: 451.7 ± 34.3 ° C
Mas egzak: 722.424133
PSA:176.76000
LogP: 5.42
Presyon vapè: 0.0 ± 0.6 mmHg nan 25 ° C
Endèks refraktif: 1.604

Alyas angle nan Spiratoside B

(1β,3β,25S)-3-[(6-Deoxy-α-L-mannopyranosyl)oxy]spirost-5-en-1-yl 6-deoxy-β-D-galactopyranoside

β-D-Galactopyranoside, (1β,3β,25S)-3-[(6-deoxy-α-L-mannopyranosyl)oxy]spirost-5-en-1-yl 6-deoxy-

Liriopesides B

Spirostan, β-D-galactopyranoside deriv.

Liriopeside b

Nolinospiroside F

Kontwòl Kalite pwodwi

1. konpayi an te achte nikleyè mayetik sonorite (Bruker 400MHz) spectromètre, likid faz mas spectrometer (LCMS), gaz faz mas spectrometer (GCMs), mas spectrometer (dlo SQD), plizyè otomatik analyse segondè pèfòmans likid chromatographs, preparative likid chromatographs, etc. .
2. Konpayi an kenbe koperasyon sere ak kontak ak enstitisyon rechèch syantifik tankou Shanghai Enstiti pou kontwòl dwòg, Nanjing byomedikal platfòm sèvis piblik ak analiz ak tès sant nan Shanghai Pharmaceutical Industry Research Institute.
3. Konpayi an ap fè aktivman tès ak sètifikasyon laboratwa twazyèm pati, epi li pral jwenn sètifika akreditasyon laboratwa CNA nan fen 2021.


  • Previous:
  • Pwochen:

  • Ekri mesaj ou a isit la epi voye li ba nou